In: BHRT 101|BHRT for Women|For Physicians|For Women|Menopause
December 22, 2009 — Postmenopausal women taking either a tricyclic antidepressant (TCA) or a selective serotonin-reuptake inhibitor (SSRI) appear to be at increased risk for all-cause mortality, and SSRI users seem to be at increased risk for hemorrhagic and fatal stroke, although the absolute event risks are low, according to an analysis from the Women’s Health Initiative (WHI) study.
For the rest of this article published in the December issue of the Archives of Internal Medicine, Jordan Smoller, MD, from Massachusetts General Hospital, Boston, and colleagues CLICK HERE
The goal of SimplyBHRT is to be your resource for all BHRT questions and news. The Healthy Choice opened its doors in 1996, and we have been caring for all of our patients compounding, pharmaceutical, pain relief and holistic needs. Let our compounding expertise and holistic approach to medicine help you with any BHRT questions you may have.